Infection Dashboard
Confirmed, ruled-out, and past infections from specialty and standard labs
IGeneX Tick-Borne Disease Results — Feb 2026
Specialty testing revealed 3 tick-borne infections missed by standard labs. Lyme negative, but co-infections confirmed.
Current Treatment Protocol
BartCore
1 dropper nightly
Started ~March 3, 2026 · Duration: 6–12 months
Ingredients:
Herbal antimicrobial targeting Bartonella
gentleBind
1 capsule daily · Herx prevention
Binder to prevent Herxheimer reactions
Ingredients:
✅ No Herx reactions — protocol working well
Treatment started ~3 weeks ago with excellent tolerance. No adverse reactions reported.
🌕 Sweet Annie (Artemisinin)
Lunar cycle addition — 7 days on, 21 days off
First cycle: March 25-31, 2026
Anti-parasitic targeting Babesia during full moon activity peaks
All Infections Tested
Bartonellosis
Bartonella elizabethae
Test Date
Feb 13, 2026
Lab
IGeneX
Test Type
IgG Antibody
Result
POSITIVE
Confirmed Bartonella elizabethae infection. Previously tested NEGATIVE for B. henselae at Quest (Mar 2024). IGeneX specialty testing detected different species.
Babesiosis
Babesia microti
Test Date
Feb 13, 2026
Lab
IGeneX
Test Type
IgM Antibody
Result
POSITIVE (IgM — acute infection)
IgM positive indicates acute/recent infection with Babesia microti (intracellular parasite affecting red blood cells). Treated with lunar-timed Sweet Annie (Artemisinin) during 7-day full moon windows to target parasitic activity peaks.
Tick-Borne Relapsing Fever (TBRF)
TBRF Borrelia species
Test Date
Feb 13, 2026
Lab
IGeneX
Test Type
Antibody Panel
Result
POSITIVE
TBRF is caused by different Borrelia species than classic Lyme disease. Can cause relapsing fever episodes, fatigue, and neurological symptoms. Often missed by standard testing.
Mycoplasma Infection
Mycoplasma pneumoniae
Test Date
Nov 25, 2025
Lab
Quest Diagnostics
Test Type
IgG Antibody
Result
POSITIVE (2.39 ISR, ref <0.90)
Seroconversion confirmed — was NEGATIVE in Mar 2024. Associated with hs-CRP surge to 5.4 (9x increase). Driving systemic inflammation.
Lyme Disease
Borrelia burgdorferi
Test Date
Feb 13, 2026
Lab
IGeneX
Test Type
Full Lyme Panel
Result
NEGATIVE (all standard tests)
Classic Lyme ruled out despite other tick-borne infections being present. This is common — co-infections without Lyme occur frequently.
CMV (Cytomegalovirus)
CMV
Test Date
Mar 22, 2024
Lab
Quest Diagnostics
Test Type
IgG/IgM
Result
IgG Positive (past exposure), IgM Negative
Past exposure — not active. IgG stable between 2024 and 2025 draws.
Bartonella henselae
Bartonella henselae
Test Date
Mar 22, 2024
Lab
Quest Diagnostics
Test Type
IgG Antibody
Result
NEGATIVE
Standard Quest testing was negative for B. henselae. However, IGeneX later found a different species (B. elizabethae). Highlights importance of specialty lab testing.
IGeneX vs Standard Labs
Standard labs (Quest) tested negative for Bartonella henselae in March 2024. IGeneX specialty testing in February 2026 detected Bartonella elizabethae — a different species not covered by standard panels. This underscores the importance of specialty tick-borne disease testing, especially when clinical suspicion is high despite negative standard results.
Quest (Mar 2024)
B. henselae: ❌ Negative
Mycoplasma: ❌ Negative
hs-CRP: 0.6 (low)
IGeneX (Feb 2026)
B. elizabethae: ✅ Positive
Babesia microti: ✅ Positive
TBRF Borrelia: ✅ Positive